Use of fish oil supplements does not significantly reduce rate of failure of grafts for hemodialysis

May 2, 2012, JAMA and Archives Journals

Among patients with new synthetic arteriovenous grafts (a synthetic tube grafted between an artery and vein) for vascular access for hemodialysis, daily ingestion of fish oil did not decrease the proportion of grafts with loss of patency (remaining open) within 12 months, according to a study in the May 2 issue of JAMA. However, fish oil recipients had a longer time without thrombosis (formation of a blood clot), half the thrombosis rate, and a clinically meaningful reduction in frequency of radiological and surgical interventions.

“Optimal hemodialysis requires reliable vascular access. Current options include the arteriovenous fistula [surgical creation of a connection between an artery and vein], synthetic arteriovenous graft, and central venous catheter, which in the United States are used in 55 percent, 21 percent, and 24 percent of prevalent patients receiving hemodialysis, respectively. The arteriovenous graft was the predominant vascular access type in North America during the early 1990s but fell out of favor owing to its high complication rates and associated costs.

Charmaine E. Lok, M.D., M.Sc., of the University of Toronto and Toronto General Hospital, and colleagues conducted a randomized controlled trial that compared arteriovenous graft patency and rates of and intervention in patients with end-stage renal disease who received supplementation vs. placebo following creation of an arteriovenous graft. The study was conducted at 15 North American dialysis centers from November 2003 through December 2010, enrolling 201 adults with stage 5 chronic kidney disease (50 percent women, 63 percent white, 53 percent with diabetes), with follow-up for 12 months after graft creation. The participants were randomly allocated to receive fish oil capsules (four 1-gram capsules/day) or matching placebo on day 7 after graft creation. The primary outcome measure for the study was the proportion of participants experiencing graft thrombosis or radiological or surgical intervention during 12 months of follow-up.

The researchers found that there was no significant difference in the proportion of fish oil recipients and placebo recipients with loss of native patency (48 percent [48/99] vs. 62 percent [60/97], respectively. “However, the rate of these events was significantly lower in the fish oil group. The frequency of thrombosis events was reduced by half in the fish oil group, and the frequency of corrective interventions was lower.”

The 12-month event-free rate (i.e., no loss of native patency of arteriovenous graft) was 48 percent in the fish oil group, compared with 32 percent in the placebo group. The reasons for arteriovenous graft loss were similar between treatment groups. The 12-month thrombosis-free rate was higher in the fish oil group (64 percent vs. 47 percent).

The researchers note that the use of arteriovenous grafts has declined over the last 10 years, largely driven by the emphasis on use of fistulas. “Arteriovenous grafts may be suitable for patients receiving hemodialysis whose veins are unsuitable for fistula creation or who have experienced prior problems with fistula nonmaturation. However, compared with functioning fistulas, arteriovenous grafts may require a 3- to 4-fold higher frequency of interventions to maintain equivalent long-term patency. Identification of safe and inexpensive agents that prolong arteriovenous graft patency and reduce the frequency of interventions to salvage complications might encourage increased use of grafts.”

Explore further: Everyday fish oil capsule may provide kidney-related benefits

More information: JAMA. 2012;307[17]:1809-1816

Related Stories

Everyday fish oil capsule may provide kidney-related benefits

May 1, 2012
Over the past decade, there has been a steady stream of information promoting the health benefits of fish oil capsules. According to Dr. Louise Moist, a Scientist at Lawson Health Research Institute, fish oil may also improve ...

Hemodialysis vascular access modifies the association between dialysis modality and survival

April 21, 2011
Patients on peritoneal dialysis (PD) typically have a higher early survival rate than patients on hemodialysis (HD). New data suggest that this difference may be explained by a higher risk of early deaths among patients undergoing ...

Recommended for you

Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies

November 13, 2018
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...

Scientists illuminate causes of hepatitis B virus-associated acute liver failure

November 13, 2018
National Institutes of Health scientists and their collaborators found that hepatitis B virus (HBV)-associated acute liver failure (ALF)—a rare condition that can turn fatal within days without liver transplantation—results ...

New strategy discovered toward possible prevention of cancers tied to mono, the 'kissing disease'

November 12, 2018
Researchers from the University of Minnesota, the Howard Hughes Medical Institute, and the University of Toronto have discovered a possible path forward in preventing the development of cancers tied to two viruses, including ...

Combination therapy promising against blindness-causing bacterial keratitis

November 12, 2018
Multidrug-resistant bacterial infections of the cornea are a leading cause of blindness and cannot be effectively managed with current ophthalmic antibiotics. A team of investigators has now devised a combination therapy ...

Hepatitis C treatment can be shortened in 50 percent of patients, study finds

November 12, 2018
Hepatitis C drugs cure more than 90 percent of patients, but can cost more than $50,000 per patient.

Salmonella found to be resistant to different classes of antibiotics

November 12, 2018
Brazil's Ministry of Health received reports of 11,524 outbreaks of foodborne diseases between 2000 and 2015, with 219,909 individuals falling sick and 167 dying from such diseases. Bacteria caused most outbreaks of such ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.